REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/01/2025
Back to search
Official data from USPTO
PAIDION RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PAIDION RESEARCH
ST13
US500000086585274Class
35, 42
Filing
86585274
Registration
4967387
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
06/02/2025
Trademark type
Word
Nice classes
35, 42
Filing date
04/02/2015
Registration date
05/31/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/18/2021
Last transaction
06/02/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
03/28/2013
First use in commerce
03/28/2013
Drawing code
4
Owner type
16
Owner location
MORRISVILLE, NC
Examiner
VIGIL, JACOB
Law office
M40
Current location
TMO LAW OFFICE 113
Holders and representatives
Holders
PREMIER RESEARCH INTERNATIONAL LLC
Paidion Research, Inc.
Representatives
Devon E. White Wyrick Robbins Yates & Ponton Llp
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business and regulatory submission management consulting servicesnamely providing assistance with regulatory filings for new pharmaceuticals with governmental regulatory bodies and product labeling for new pharmaceuticalsspecifically pharmaceuticals for use with pediatric patients; Consulting services regarding regulatory registration in the nature of regulatory submission managementassisting others in preparing and filing applications for new pharmaceuticals with governmental regulatory bodies
Class 42
Clinical research servicesnamely population modeling and trial simulations used to develop drug programs for pediatric clinical research; Scientific research consulting servicesnamely providing assistance with creating protocol designs through pharmaceutical testing and technical writing of product labels othersspecifically for pharmaceuticals for use with pediatric patients; Technical writing services for others
Publications
History of USPTO decisions and trademark events.
22 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/01/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/18/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/18/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/18/2021
E815
TEAS SECTION 8 & 15 RECEIVED
06/03/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/31/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
05/31/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/15/2016
PUBO
PUBLISHED FOR OPPOSITION
03/15/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/24/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/03/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/20/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/20/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/20/2016
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
07/20/2015
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
07/20/2015
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
07/20/2015
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
07/20/2015
DOCK
ASSIGNED TO EXAMINER
07/10/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/13/2015
NWAP
NEW APPLICATION ENTERED
04/06/2015
Continuous trademark protection
Get notified about every new filing that threatens PAIDION RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.